Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032725

Chief Financial Officer gave up 228 shares (to pay taxes)

  • Chief Financial Officer acquired 464 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2025-03-03 Shares withheld for taxes −228 $60.58 $13,812 12,570 D: show line 1 in the form
Mokari Atabak Chief Financial Officer 2025-03-03 Grant or award +232 $59.07 $13,704 12,802 D: show line 2 in the form
Mokari Atabak Chief Financial Officer 2025-03-03 Grant or award +232 13,034 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mokari Atabak Chief Financial Officer 2025-02-28 Grant or award · Stock option (right to buy) +140,000 140,000 D: show line 4 in the form
Loading xslF345X05/ownership.xml…